FLG and Alzheimer disease: This work additionally further informs mechanistic pathways in AD, demonstrating that TEWL in patients with moderate-to-severe AD is an outcome that is independent of FLG mutation status and pointing to a complex systemic interplay of environmental, immunologic, and functional pathways in the genesis of epithelial barrier disruption in patients with AD.